Vident Investment Advisory’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,537
| Closed | -$736K | – | 1194 |
|
|
2023
Q1 | $736K | Buy |
1,537
+391
| +34% | +$187K | 0.02% | 625 |
|
|
2022
Q4 | $482K | Buy |
1,146
+196
| +21% | +$82.4K | 0.02% | 733 |
|
|
2022
Q3 | $362K | Buy |
950
+324
| +52% | +$123K | 0.01% | 853 |
|
|
2022
Q2 | $301K | Sell |
626
-1,662
| -73% | -$799K | 0.01% | 1011 |
|
|
2022
Q1 | $1.29M | Buy |
2,288
+327
| +17% | +$184K | 0.03% | 606 |
|
|
2021
Q4 | $1.48M | Buy |
1,961
+789
| +67% | +$596K | 0.04% | 577 |
|
|
2021
Q3 | $874K | Buy |
1,172
+75
| +7% | +$55.9K | 0.03% | 725 |
|
|
2021
Q2 | $708K | Sell |
1,097
-67
| -6% | -$43.2K | 0.02% | 748 |
|
|
2021
Q1 | $665K | Buy |
1,164
+59
| +5% | +$33.7K | 0.02% | 712 |
|
|
2020
Q4 | $645K | Buy |
1,105
+12
| +1% | +$7.01K | 0.03% | 648 |
|
|
2020
Q3 | $563K | Sell |
1,093
-83
| -7% | -$42.8K | 0.03% | 638 |
|
|
2020
Q2 | $531K | Buy |
+1,176
| New | +$531K | 0.03% | 628 |
|
|
2015
Q4 | – | Sell |
-6,378
| Closed | -$857K | – | 427 |
|
|
2015
Q3 | $857K | Buy |
+6,378
| New | +$857K | 0.12% | 242 |
|